September 24, 2005. The Food and Drug Administration (FDA) issued an “approvable letter” to Inamed Corporation for their silicone gel breast implants, and NCHR finds this unacceptable.
Read More »Author: NCHR Author
NCHR Statement on FDA Breast Implant Decision
July 28, 2005. The Food and Drug Administration (FDA) has issued an “approvable letter” to Mentor regarding their silicone gel breast implants. This does not mean that these implants have been approved, but it is a warning sign that corporate pressure on the FDA has once again put women’s health at risk.
Read More »FDA Panel Votes 7-To-2 To Lift Restrictions On Mentor’s Silicone Breast Implants, With Unusually Large Number Of Post-Market Conditions
April 13, 2005. An FDA panel voted to put Mentor Corporation’s silicone gel breast implants back on the market with nine conditions, after rejecting a previous company’s application the day before.
Read More »NCHR Statement on Protecting Patients from Long-Term Risks
February 17, 2005. When Americans take medication, they don’t expect to have to read the studies that have been conducted on the product.
Read More »State of the Union and Social Security
February 2, 2005. In tonight’s State of the Union speech, President Bush made his case to privatize Social Security.
Read More »